Thomas F. Gajewski
Nessuna posizione attualmente
Profilo
Thomas F.
Gajewski is the founder of Jounce Therapeutics, Inc. (founded in 2013).
Dr. Gajewski is also the founder of Pyxis Oncology, Inc. He received his undergraduate and doctorate degrees from The University of Chicago.
Precedenti posizioni note di Thomas F. Gajewski
| Società | Posizione | Fine |
|---|---|---|
| PYXIS ONCOLOGY, INC. | Fondatore | - |
| JOUNCE THERAPEUTICS, INC. | Fondatore | - |
Formazione di Thomas F. Gajewski
| The University of Chicago | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PYXIS ONCOLOGY, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Jounce Therapeutics, Inc.
 Jounce Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which engages in developing treatments for cancer. It also provides novel cancer immunotherapies to attack tumors. The company was founded by Louis M. Weiner, Drew M. Pardoll, Thomas F. Gajewski, James P. Allison, Robert Schreiber, and Padmanee Sharma in 2013 and is headquartered in Cambridge, MA. | Commercial Services |
- Borsa valori
- Insiders
- Thomas F. Gajewski
